What is the stage of a gastric adenocarcinoma that has directly invaded the first portion of the duodenum, causing gastric outlet obstruction and associated with abdominal lymphadenopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Staging of Gastric Adenocarcinoma with Duodenal Invasion and Lymphadenopathy

This gastric adenocarcinoma with direct invasion into the first portion of the duodenum is classified as T4 disease, and when combined with abdominal lymphadenopathy, represents at minimum Stage IIB-IIIC disease depending on the number of involved lymph nodes, but requires complete staging workup to exclude metastatic (Stage IV) disease.

T-Stage Classification

According to the TNM staging system, intramural extension to the duodenum is classified by the depth of the greatest invasion 1. The key distinction is:

  • T4a: Tumor invades the serosa (visceral peritoneum) - considered resectable
  • T4b: Tumor invades adjacent structures (spleen, colon, liver, diaphragm, pancreas, etc.) - more advanced

Critically, the guidelines explicitly state that "intramural extension to the duodenum or oesophagus is classified by the depth of the greatest invasion in any of these sites, including the stomach" 1. This means duodenal invasion itself doesn't automatically make it T4b - the depth of invasion determines the T stage.

However, gastric outlet obstruction indicates significant tumor burden and typically correlates with T4a disease at minimum 2. The presence of obstruction suggests either serosal penetration or extensive transmural involvement.

N-Stage Classification

The lymphadenopathy must be quantified by number of involved nodes 1, 3:

  • N1: 1-6 positive regional lymph nodes
  • N2: 7-15 positive regional lymph nodes
  • N3: >15 positive regional lymph nodes

Research data shows that gastric cancer with duodenal invasion has significantly higher rates of N3 metastasis (60%) compared to those without duodenal invasion (36%) 4. The presence of "lymphadenopathy" on imaging requires pathological confirmation, but clinically suggests at least N1 disease.

Overall Stage Grouping

Combining T4 with nodal involvement yields:

  • T4a N1 = Stage IIIA
  • T4a N2 = Stage IIIB
  • T4a N3 = Stage IIIC
  • T4b (any N) = Stage IIIC

Critical Staging Requirements Before Final Classification

You must complete the following staging steps before finalizing treatment 1, 3:

  1. CT chest/abdomen/pelvis - to exclude distant metastases (M1 disease would make this Stage IV)

  2. Diagnostic laparoscopy with peritoneal washings - mandatory for all potentially resectable cases 1, 3. This identifies occult peritoneal disease in up to 16% of cases 3. Positive peritoneal cytology is classified as M1 disease (Stage IV) 3.

  3. Endoscopic ultrasound (EUS) - determines exact depth of invasion and proximal/distal extent 1

  4. PET scan (if available) - may upstage disease but can be negative in diffuse/mucinous tumors 1

Clinical Implications and Prognosis

The prognosis for gastric cancer with duodenal invasion is significantly worse than without invasion 4, 5. Research shows:

  • 5-year survival with duodenal invasion: 14-35% (with curative resection)
  • 5-year survival without duodenal invasion: 43%
  • Patients with pyloric stenosis/gastric outlet obstruction have even poorer prognosis 4

The presence of gastric outlet obstruction in this case is particularly concerning as it indicates advanced local disease and correlates with higher rates of:

  • Serosal invasion (91% vs 76%) 4
  • Pancreatic head infiltration 4
  • N3 nodal metastasis 4

Treatment Approach Based on Staging

If staging confirms locally advanced resectable disease (Stage IIB-IIIC, M0):

  • Perioperative FLOT chemotherapy is the standard of care 6, 7
  • Gastrectomy with 3-4 cm duodenal resection and D2 lymphadenectomy 2, 5
  • Extended surgery with combined organ resection may be required 2

If staging reveals Stage IV disease (M1):

  • Palliative chemotherapy is primary treatment 2, 8, 7
  • Palliative gastrojejunostomy for gastric outlet obstruction (stomach-partitioning technique superior to simple bypass) 2
  • Reduction surgery (gastrectomy in metastatic disease) is NOT recommended outside clinical trials 2, 8

Common Pitfalls to Avoid

  1. Do not assume duodenal invasion automatically means unresectable disease - it may still be T4a and amenable to curative resection 3

  2. Do not proceed to surgery without laparoscopy - you will miss occult peritoneal disease in a significant percentage of cases 3

  3. Do not underestimate nodal burden - minimum 15 lymph nodes must be examined for adequate staging 3, 6

  4. Do not offer reduction surgery for symptom-free metastatic disease - the REGATTA trial showed no survival benefit 2, 8

References

7
Guideline

gastric cancer, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Related Questions

What is the recommended management for early gastric cancer limited to the mucosa or superficial submucosa with no lymphovascular invasion?
What molecular tests and targeted treatment options are recommended for a patient with gastric adenocarcinoma?
Based on my relative’s stage IV gastrointestinal adenocarcinoma chart, do you agree with the proposed treatment plan?
Should I limit kimchi consumption to reduce my risk of gastric cancer, and what screening or treatment recommendations apply?
Does having a single first-degree relative diagnosed with gastric (stomach) cancer require any special cancer screening for the daughter?
What is the maximum recommended dose of tranexamic acid for adults (both oral and intravenous)?
How should a 30-year-old woman at 11 weeks gestation with an asymptomatic positive routine antenatal screen for Chlamydia trachomatis be managed?
In a patient with cerebrospinal fluid glucose 48 mg/dL, protein 28 mg/dL, and a lymphocyte‑predominant (mononuclear) pleocytosis, what is the most likely diagnosis and appropriate initial treatment?
What postoperative surveillance and adjuvant therapy is recommended for a patient with stage IB3 (pT1b3, pN0) cervical cancer after 14 pelvic lymph nodes were examined and found negative?
In a patient with liver carcinoma and stable vital signs, with normal electrolytes (Na 140 mmol/L, K 3.7 mmol/L, Cl 103 mmol/L), what is the appropriate isotonic crystalloid for rehydration?
What is the appropriate management for a skin burn caused by a plaster cast?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.